Monday 28 May 2012

Food And Drug Administration-Neurodegenerative Disease-International Group-Fatal Condition

Emergency plan launched for endgame of polio eradication

The international group tasked with ridding the world of polio said on Thursday it was shifting to "emergency mode" as the fight enters its final stretch. read more..


U.S. panel split on Pfizer rare disease drug

(Reuters) - A U.S. health advisory panel on Thursday issued a split vote on data for Pfizer Inc's drug to treat a rare neurodegenerative disease. The U.S. Food And Drug Administration panel voted 13 to 4 that the drug did not show that it met the main goal in a study in treating the fatal condition. However, the panel also voted 13 to 4 that the drug treated a surrogate endpoint, which may correlate with treating the underlying disease. The panel's recommendation will be considered by the U.S. ... read more..

No comments:

Post a Comment